China IVIG Industry Market Research Report 2023-2029

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • This report elaborates on the current development of the IVIG industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • BSV

    • RAAS

    • RUIDE Bio

    • BOYA Bio

    • Kangbao Bio

    • Green Cross

    • Weilun Bio

    • RUIDE Bio

    • WIBP

    • SIBP

    • Hualan Bio

    • Weiguang Bio

    • Taibang Bio

    • Tiantan Bio

    By Type:

    • Lyophilized Powder

    • Injection

    By Application:

    • Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)

    • Dermatomyositis

    • Polymyositis

    • Multifocal Motor Neuropathy (MMN)

    • Multiple Sclerosis (MS)

    • Myasthenia Gravis (MG)

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China IVIG Market Overview 2018-2029

    • 1.1 China IVIG Industry Development Overview

    • 1.2 China IVIG Industry Development History

    • 1.3 China IVIG Industry Market Size (2018-2029)

    • 1.4 China IVIG Market Analysis by Type from Production Side

      • 1.4.1 China IVIG Production Volume, Production Value and Growth Rate of Lyophilized Powder (2018-2029)

      • 1.4.2 China IVIG Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • 1.5 China IVIG Market Analysis by Application from Consumption End

      • 1.5.1 China IVIG Sales Volume, Sales Value and Growth Rate of Multifocal Acquired Sensory and Motor Neuropathy (MADSAM) (2018-2029)

      • 1.5.2 China IVIG Sales Volume, Sales Value and Growth Rate of Dermatomyositis (2018-2029)

      • 1.5.3 China IVIG Sales Volume, Sales Value and Growth Rate of Polymyositis (2018-2029)

      • 1.5.4 China IVIG Sales Volume, Sales Value and Growth Rate of Multifocal Motor Neuropathy (MMN) (2018-2029)

      • 1.5.5 China IVIG Sales Volume, Sales Value and Growth Rate of Multiple Sclerosis (MS) (2018-2029)

      • 1.5.6 China IVIG Sales Volume, Sales Value and Growth Rate of Myasthenia Gravis (MG) (2018-2029)

    • 1.6 China IVIG Market Analysis by Region

      • 1.6.1 North China IVIG Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China IVIG Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China IVIG Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China IVIG Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China IVIG Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China IVIG Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China IVIG Market Size and Growth Rate from 2018-2029

    Chapter 2 China IVIG Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on IVIG Market Status and Competition at home and abroad in 2023

      • 2.2.2 China IVIG Market Status and Competition Analysis in 2023

      • 2.2.3 China IVIG Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China IVIG Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on IVIG Industry Development

    Chapter 3 IVIGIndustry Chain Analysis

    • 3.1 IVIG Industry Chain

    • 3.2 IVIG Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the IVIG Market

    • 3.3 IVIG Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the IVIG Market

    Chapter 4 China IVIG Market, by Type

    • 4.1 China IVIG Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China IVIG Total Production Volume and Growth Rate from Production Side

    • 4.5 China IVIG Production Volume and Growth Rate, by Type

      • 4.5.1 China IVIG Production Volume and Growth Rate of Lyophilized Powder

      • 4.5.2 China IVIG Production Volume and Growth Rate of Injection

    Chapter 5 China IVIG Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China IVIG Total Market Size and Growth Rate from Consumption End

    • 5.5 China IVIG Market Size and Growth Rate, by Application

      • 5.5.1 China IVIG Market Size and Growth Rate of Multifocal Acquired Sensory and Motor Neuropathy (MADSAM)

      • 5.5.2 China IVIG Market Size and Growth Rate of Dermatomyositis

      • 5.5.3 China IVIG Market Size and Growth Rate of Polymyositis

      • 5.5.4 China IVIG Market Size and Growth Rate of Multifocal Motor Neuropathy (MMN)

      • 5.5.5 China IVIG Market Size and Growth Rate of Multiple Sclerosis (MS)

      • 5.5.6 China IVIG Market Size and Growth Rate of Myasthenia Gravis (MG)

    Chapter 6 China IVIG Market, by Region

    • 6.1 China IVIG Production Volume and Production Value, by Region

    • 6.2 China IVIG Sales Volume and Sales Value, by Region

    Chapter 7 North China IVIG Market Analysis

    • 7.1 North China IVIG Market, by Type

    • 7.2 North China IVIG Market, by Application

    Chapter 8 Central China IVIG Market Analysis

    • 8.1 Central China IVIG Market, by Type

    • 8.2 Central China IVIG Market, by Application

    Chapter 9 South China IVIG Market Analysis

    • 9.1 South China IVIG Market, by Type

    • 9.2 South China IVIG Market, by Application

    Chapter 10 East China IVIG Market Analysis

    • 10.1 East China IVIG Market, by Type

    • 10.2 East China IVIG Market, by Application

    Chapter 11 Northeast China IVIG Market Analysis

    • 11.1 Northeast China IVIG Market, by Type

    • 11.2 Northeast China IVIG Market, by Application

    Chapter 12 Southwest China IVIG Market Analysis

    • 12.1 Southwest China IVIG Market, by Type

    • 12.2 Southwest China IVIG Market, by Application

    Chapter 13 Northwest China IVIG Market Analysis

    • 13.1 Northwest China IVIG Market, by Type

    • 13.2 Northwest China IVIG Market, by Application

    Chapter 14 Company Profiles

      • 14.1 BSV

        • 14.1.1 BSV Company Profile

        • 14.1.2 BSV IVIG Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 RAAS

        • 14.2.1 RAAS Company Profile

        • 14.2.2 RAAS IVIG Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 RUIDE Bio

        • 14.3.1 RUIDE Bio Company Profile

        • 14.3.2 RUIDE Bio IVIG Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 BOYA Bio

        • 14.4.1 BOYA Bio Company Profile

        • 14.4.2 BOYA Bio IVIG Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Kangbao Bio

        • 14.5.1 Kangbao Bio Company Profile

        • 14.5.2 Kangbao Bio IVIG Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Green Cross

        • 14.6.1 Green Cross Company Profile

        • 14.6.2 Green Cross IVIG Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Weilun Bio

        • 14.7.1 Weilun Bio Company Profile

        • 14.7.2 Weilun Bio IVIG Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 RUIDE Bio

        • 14.8.1 RUIDE Bio Company Profile

        • 14.8.2 RUIDE Bio IVIG Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 WIBP

        • 14.9.1 WIBP Company Profile

        • 14.9.2 WIBP IVIG Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 SIBP

        • 14.10.1 SIBP Company Profile

        • 14.10.2 SIBP IVIG Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Hualan Bio

        • 14.11.1 Hualan Bio Company Profile

        • 14.11.2 Hualan Bio IVIG Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Weiguang Bio

        • 14.12.1 Weiguang Bio Company Profile

        • 14.12.2 Weiguang Bio IVIG Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Taibang Bio

        • 14.13.1 Taibang Bio Company Profile

        • 14.13.2 Taibang Bio IVIG Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Tiantan Bio

        • 14.14.1 Tiantan Bio Company Profile

        • 14.14.2 Tiantan Bio IVIG Market Performance

        • 14.14.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 IVIG Industry Research Conclusions

    • 15.2 IVIG Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China IVIG Industry Market Size (2018-2029)

    • Figure China IVIG Production Volume, Production Value and Growth Rate of Lyophilized Powder (2018-2029)

    • Figure China IVIG Production Volume, Production Value and Growth Rate of Injection (2018-2029)

    • Figure China IVIG Sales Volume, Sales Value and Growth Rate of Multifocal Acquired Sensory and Motor Neuropathy (MADSAM) (2018-2029)

    • Figure China IVIG Sales Volume, Sales Value and Growth Rate of Dermatomyositis (2018-2029)

    • Figure China IVIG Sales Volume, Sales Value and Growth Rate of Polymyositis (2018-2029)

    • Figure China IVIG Sales Volume, Sales Value and Growth Rate of Multifocal Motor Neuropathy (MMN) (2018-2029)

    • Figure China IVIG Sales Volume, Sales Value and Growth Rate of Multiple Sclerosis (MS) (2018-2029)

    • Figure China IVIG Sales Volume, Sales Value and Growth Rate of Myasthenia Gravis (MG) (2018-2029)

    • Figure North China IVIG Market Size and Growth Rate from 2018-2029

    • Figure Central China IVIG Market Size and Growth Rate from 2018-2029

    • Figure South China IVIG Market Size and Growth Rate from 2018-2029

    • Figure East China IVIG Market Size and Growth Rate from 2018-2029

    • Figure Northeast China IVIG Market Size and Growth Rate from 2018-2029

    • Figure Southwest China IVIG Market Size and Growth Rate from 2018-2029

    • Figure Northwest China IVIG Market Size and Growth Rate from 2018-2029

    • Figure IVIG Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China IVIG Market Share by Type in 2018

    • Figure China IVIG Market Share by Type in 2023

    • Figure China IVIG Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China IVIG Production Volume and Growth Rate of Lyophilized Powder (2018-2023)

    • Figure China IVIG Production Volume and Growth Rate of Injection (2018-2023)

    • Figure China IVIG Market Share by Application in 2018

    • Figure China IVIG Market Share by Application in 2023

    • Figure China IVIG Total Market Size and Growth Rate from Consumption End

    • Figure China IVIG Market Size and Growth Rate of Multifocal Acquired Sensory and Motor Neuropathy (MADSAM) (2018-2023)

    • Figure China IVIG Market Size and Growth Rate of Dermatomyositis (2018-2023)

    • Figure China IVIG Market Size and Growth Rate of Polymyositis (2018-2023)

    • Figure China IVIG Market Size and Growth Rate of Multifocal Motor Neuropathy (MMN) (2018-2023)

    • Figure China IVIG Market Size and Growth Rate of Multiple Sclerosis (MS) (2018-2023)

    • Figure China IVIG Market Size and Growth Rate of Myasthenia Gravis (MG) (2018-2023)

    • Table China IVIG Production Volume by Region (2018-2023)

    • Table China IVIG Production Volume Share by Region (2018-2023)

    • Figure China IVIG Production Volume Share by Region (2018-2023)

    • Table China IVIG Production Value by Region (2018-2023)

    • Table China IVIG Production Value Share by Region (2018-2023)

    • Figure China IVIG Production Value Share by Region (2018-2023)

    • Table China IVIG Sales Volume by Region (2018-2023)

    • Table China IVIG Sales Volume Share by Region (2018-2023)

    • Figure China IVIG Sales Volume Share by Region (2018-2023)

    • Table China IVIG Sales Value by Region (2018-2023)

    • Table China IVIG Sales Value Share by Region (2018-2023)

    • Figure China IVIG Sales Value Share by Region (2018-2023)

    • Table North China IVIG Production Volume by Type (2018-2023)

    • Table North China IVIG Production Volume Share by Type (2018-2023)

    • Figure North China IVIG Production Volume Share by Type (2018-2023)

    • Table North China IVIG Sales Volume by Application (2018-2023)

    • Table North China IVIG Sales Volume Share by Application (2018-2023)

    • Figure North China IVIG Sales Volume Share by Application (2018-2023)

    • Table Central China IVIG Production Volume by Type (2018-2023)

    • Table Central China IVIG Production Volume Share by Type (2018-2023)

    • Figure Central China IVIG Production Volume Share by Type (2018-2023)

    • Table Central China IVIG Sales Volume by Application (2018-2023)

    • Table Central China IVIG Sales Volume Share by Application (2018-2023)

    • Figure Central China IVIG Sales Volume Share by Application (2018-2023)

    • Table South China IVIG Production Volume by Type (2018-2023)

    • Table South China IVIG Production Volume Share by Type (2018-2023)

    • Figure South China IVIG Production Volume Share by Type (2018-2023)

    • Table South China IVIG Sales Volume by Application (2018-2023)

    • Table South China IVIG Sales Volume Share by Application (2018-2023)

    • Figure South China IVIG Sales Volume Share by Application (2018-2023)

    • Table East China IVIG Production Volume by Type (2018-2023)

    • Table East China IVIG Production Volume Share by Type (2018-2023)

    • Figure East China IVIG Production Volume Share by Type (2018-2023)

    • Table East China IVIG Sales Volume by Application (2018-2023)

    • Table East China IVIG Sales Volume Share by Application (2018-2023)

    • Figure East China IVIG Sales Volume Share by Application (2018-2023)

    • Table Northeast China IVIG Production Volume by Type (2018-2023)

    • Table Northeast China IVIG Production Volume Share by Type (2018-2023)

    • Figure Northeast China IVIG Production Volume Share by Type (2018-2023)

    • Table Northeast China IVIG Sales Volume by Application (2018-2023)

    • Table Northeast China IVIG Sales Volume Share by Application (2018-2023)

    • Figure Northeast China IVIG Sales Volume Share by Application (2018-2023)

    • Table Southwest China IVIG Production Volume by Type (2018-2023)

    • Table Southwest China IVIG Production Volume Share by Type (2018-2023)

    • Figure Southwest China IVIG Production Volume Share by Type (2018-2023)

    • Table Southwest China IVIG Sales Volume by Application (2018-2023)

    • Table Southwest China IVIG Sales Volume Share by Application (2018-2023)

    • Figure Southwest China IVIG Sales Volume Share by Application (2018-2023)

    • Table Northwest China IVIG Production Volume by Type (2018-2023)

    • Table Northwest China IVIG Production Volume Share by Type (2018-2023)

    • Figure Northwest China IVIG Production Volume Share by Type (2018-2023)

    • Table Northwest China IVIG Sales Volume by Application (2018-2023)

    • Table Northwest China IVIG Sales Volume Share by Application (2018-2023)

    • Figure Northwest China IVIG Sales Volume Share by Application (2018-2023)

    • Table BSV Company Profile

    • Table BSV IVIG Revenue, Price and Gross (2018-2023)

    • Table RAAS Company Profile

    • Table RAAS IVIG Revenue, Price and Gross (2018-2023)

    • Table RUIDE Bio Company Profile

    • Table RUIDE Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table BOYA Bio Company Profile

    • Table BOYA Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table Kangbao Bio Company Profile

    • Table Kangbao Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table Green Cross Company Profile

    • Table Green Cross IVIG Revenue, Price and Gross (2018-2023)

    • Table Weilun Bio Company Profile

    • Table Weilun Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table RUIDE Bio Company Profile

    • Table RUIDE Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table WIBP Company Profile

    • Table WIBP IVIG Revenue, Price and Gross (2018-2023)

    • Table SIBP Company Profile

    • Table SIBP IVIG Revenue, Price and Gross (2018-2023)

    • Table Hualan Bio Company Profile

    • Table Hualan Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table Weiguang Bio Company Profile

    • Table Weiguang Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table Taibang Bio Company Profile

    • Table Taibang Bio IVIG Revenue, Price and Gross (2018-2023)

    • Table Tiantan Bio Company Profile

    • Table Tiantan Bio IVIG Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.